Year archive

Opthea Ltd — 2017 filings

All 49 regulatory filings released by Opthea Ltd (OPT) in 2017, sourced directly from the official regulator.

49 Filings

2017 Period

2017 filings (49)

Filing	Released	Lang
Change in substantial holding 3 pages 175.3KB Regulatory Filings	2017-12-21	English
Change in substantial holding 33 pages 1.0MB Regulatory Filings	2017-12-18	English
Opthea Doses First Patient in OPT-302 wAMD Ph2b trial 4 pages 314.8KB Regulatory Filings	2017-12-18	English
Change in substantial holding (Full copy) 34 pages 1.1MB Regulatory Filings	2017-12-18	English
Appendix 3B 13 pages 158.2KB Regulatory Filings	2017-12-14	English
Opthea Chairman's Address to the 2017 AGM 3 pages 71.5KB Regulatory Filings	2017-11-22	English
Opthea CEO Presentation to the 2017 AGM 28 pages 2.1MB Regulatory Filings	2017-11-22	English
Results of Meeting 1 page 41.0KB Regulatory Filings	2017-11-22	English
Appendix 3B 13 pages 158.4KB Regulatory Filings	2017-11-20	English
Notice of Annual General Meeting and Proxy Form 19 pages 909.1KB Regulatory Filings	2017-10-22	English
Opthea Granted Key United States Patent Covering OPT-302 3 pages 73.0KB Regulatory Filings	2017-08-30	English
Opthea Appendix 4E and Annual Report 2017 89 pages 7.0MB Regulatory Filings	2017-08-29	English
Appendix 4G and Corporate Governance Statement 2017 20 pages 277.1KB Regulatory Filings	2017-08-29	English
Opthea Presents Further Positive Data from OPT-302 Ph1/2A 3 pages 269.7KB Regulatory Filings	2017-08-14	English
Opthea Presents at the Ophthalmology Innovation Summit 3 pages 311.1KB Regulatory Filings	2017-08-10	English
Opthea presentation for Ophthalmology Innovation Summit 20 pages 1.2MB Regulatory Filings	2017-08-10	English
Opthea to present at the ASRS Annual Meeting and the OIS 3 pages 269.4KB Regulatory Filings	2017-08-08	English
Opthea to Present at Wedbush PacGrow Conference 2 pages 65.0KB Regulatory Filings	2017-07-31	English
Opthea Allowed Key Patent for OPT-302 in United States 3 pages 75.1KB Regulatory Filings	2017-07-05	English
Appendix 3B 13 pages 151.4KB Regulatory Filings	2017-06-29	English
Change of Director's Interest Notice - MB 3 pages 86.8KB Regulatory Filings	2017-05-08	English
Change of Director's Interest Notice - GK 3 pages 80.9KB Regulatory Filings	2017-05-08	English
Appendix 3B 13 pages 162.6KB Regulatory Filings	2017-05-02	English
Opthea Completes A$45 Million Capital Raising 3 pages 79.2KB Regulatory Filings	2017-04-27	English
Change of Director's Interest Notice - MS 2 pages 86.4KB Regulatory Filings	2017-04-26	English
Ceasing to be a substantial holder 3 pages 136.0KB Regulatory Filings	2017-04-20	English
Change in substantial holding 17 pages 6.7MB Regulatory Filings	2017-04-17	English
Appendix 3B 16 pages 228.3KB Regulatory Filings	2017-04-11	English
Placement Cleansing Statement 1 page 58.2KB Regulatory Filings	2017-04-11	English
Opthea Retail Entitlement Offer Booklet 69 pages 15.5MB Regulatory Filings	2017-04-09	English
Opthea Entitlement Offer Notice to Ineligible Shareholders 3 pages 95.9KB Regulatory Filings	2017-04-09	English
Opthea Successfully Completes Institutional Capital Raising 5 pages 285.4KB Regulatory Filings	2017-04-04	English
ASX Notice - Accelerated Non-Renounceable Entitlement Offer 2 pages 364.9KB Regulatory Filings	2017-04-04	English
Trading Halt 2 pages 289.8KB Regulatory Filings	2017-04-02	English
Opthea Reports Positive Phase 1/2A Clinical Results 4 pages 100.4KB Regulatory Filings	2017-04-02	English
Opthea Phase 1/2A wet AMD Trial Update Presentation 21 pages 1.6MB Regulatory Filings	2017-04-02	English
Opthea Launches A$45M Financing for Clinical Development 5 pages 69.4KB Regulatory Filings	2017-04-02	English
Opthea A$45M Equity Raising Launch Presentation 27 pages 894.0KB Regulatory Filings	2017-04-02	English
Appendix 3B 14 pages 218.4KB Regulatory Filings	2017-04-02	English
Entitlement Offer Cleansing Statement 2 pages 96.0KB Regulatory Filings	2017-04-02	English
Opthea to Host Update on OPT-302 Phase 1/2A wAMD Trial 3 pages 266.6KB Regulatory Filings	2017-03-30	English
Trading Halt 2 pages 277.5KB Regulatory Filings	2017-03-29	English
Opthea Receives EU Regulatory Feedback for OPT-302 Program 3 pages 267.2KB Regulatory Filings	2017-03-19	English
Ceasing to be a substantial holder 2 pages 106.9KB Regulatory Filings	2017-03-12	English
Opthea Completes FDA Meeting to Inform OPT-302 Program 3 pages 266.9KB Regulatory Filings	2017-03-08	English
Opthea Half Year Report and Accounts 20 pages 655.1KB Regulatory Filings	2017-02-20	English
Change in substantial holding 3 pages 132.3KB Regulatory Filings	2017-02-13	English
Appendix 3B 13 pages 160.1KB Regulatory Filings	2017-02-05	English
Opthea Corporate Presentation during JPMorgan Conference 40 pages 2.3MB Regulatory Filings	2017-01-08	English

Filings by year

2026 4 filings
2025 97 filings
2024 150 filings
2023 108 filings
2022 143 filings
2021 117 filings
2020 100 filings
2019 59 filings
2018 52 filings
2017 49 filings
2016 27 filings
2015 1 filing
2014 46 filings
2013 38 filings
2012 43 filings
2011 47 filings
2010 42 filings
2009 38 filings
2008 56 filings
2007 34 filings
2006 29 filings
2005 20 filings
2004 27 filings
2003 57 filings
2002 5 filings